Evidence map›Paper›PMID 32631904›Full record

ArticleCancer research2020

The D2 and D3 Sublineages of Human Papilloma Virus 16-Positive Cervical Cancer in Guatemala Differ in Integration Rate and Age of Diagnosis.

Hong Lou, Joseph F Boland, Edmundo Torres-Gonzalez, Anaseidy Albanez, Weiyin Zhou, Mia K Steinberg, Lena Diaw, Jason Mitchell, David Roberson, Michael Cullen and 10 more

Open access · greenAbstract read
In one paragraph

Article in Cancer research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 4 countries.

Hong Lou *Cancer Genetics Research Laboratory, Division of Cancer Epidemiology and Genetics, Leidos Biomedical Research Inc., National Laboratory for Cancer Research, Gaithersburg, Maryland.
Joseph F Boland *Cancer Genetics Research Laboratory, Division of Cancer Epidemiology and Genetics, Leidos Biomedical Research Inc., National Laboratory for Cancer Research, Gaithersburg, Maryland.
Edmundo Torres-Gonzalez *Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, NCI, Gaithersburg, Maryland.ORCID 0000-0001-8844-2855
Anaseidy Albanez *Instituto de Cancerologia, Guatemala City, Guatemala.
Weiyin ZhouCancer Genetics Research Laboratory, Division of Cancer Epidemiology and Genetics, Leidos Biomedical Research Inc., National Laboratory for Cancer Research, Gaithersburg, Maryland.
Mia K SteinbergCancer Genetics Research Laboratory, Division of Cancer Epidemiology and Genetics, Leidos Biomedical Research Inc., National Laboratory for Cancer Research, Gaithersburg, Maryland.
Lena DiawLaboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, NCI, Gaithersburg, Maryland.
Jason MitchellCancer Genetics Research Laboratory, Division of Cancer Epidemiology and Genetics, Leidos Biomedical Research Inc., National Laboratory for Cancer Research, Gaithersburg, Maryland.
David RobersonCancer Genetics Research Laboratory, Division of Cancer Epidemiology and Genetics, Leidos Biomedical Research Inc., National Laboratory for Cancer Research, Gaithersburg, Maryland.
Michael CullenCancer Genetics Research Laboratory, Division of Cancer Epidemiology and Genetics, Leidos Biomedical Research Inc., National Laboratory for Cancer Research, Gaithersburg, Maryland.
Lisa GarlandCancer Genetics Research Laboratory, Division of Cancer Epidemiology and Genetics, Leidos Biomedical Research Inc., National Laboratory for Cancer Research, Gaithersburg, Maryland.
Sara BassCancer Genetics Research Laboratory, Division of Cancer Epidemiology and Genetics, Leidos Biomedical Research Inc., National Laboratory for Cancer Research, Gaithersburg, Maryland.
Robert D BurkDepartments of Pediatrics, Microbiology and Immunology, and Obstetrics & Gynecology and Women's Health, Albert Einstein College of Medicine, Bronx, New York.
Meredith YeagerCancer Genetics Research Laboratory, Division of Cancer Epidemiology and Genetics, Leidos Biomedical Research Inc., National Laboratory for Cancer Research, Gaithersburg, Maryland.ORCID 0000-0002-8376-8458
Nicolas WentzensenLaboratory of Cancer Genetics, Division of Cancer Epidemiology and Genetics, NCI, Gaithersburg, Maryland.
Mark SchiffmanLaboratory of Cancer Genetics, Division of Cancer Epidemiology and Genetics, NCI, Gaithersburg, Maryland.
Enrique Alvirez FreitesHospital Central Universitario "Dr. Antonio M Pineda," Barquisimeto, Lara State, Venezuela.ORCID 0000-0003-4785-0363
Eduardo GharzouziIntegra Cancer Institute, Guatemala City, Guatemala.
Lisa MirabelloLaboratory of Cancer Genetics, Division of Cancer Epidemiology and Genetics, NCI, Gaithersburg, Maryland.
Michael DeanLaboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, NCI, Gaithersburg, Maryland. deanm@mail.nih.gov.ORCID 0000-0003-2234-0631
Leidos (United States) · USCancer Genetics (United States) · USLiga Nacional Contra el Cáncer · GTAlbert Einstein College of Medicine · USUniversidad Nacional Experimental Politécnica "Antonio José de Sucre" · VE

Funding

PERSISTENT HUMAN PAPILLOMAVIRUS IN WOMEN AT RISK FOR CERVIX CANCERU01CA078527 · NCI · YESHIVA UNIVERSITY · PI BURK, ROBERT D · 2003 to 2018
$8.6M
Single Nucleotide Polymorphisms in Cancer Related GenesZ01BC005652 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI DEAN, MICHAEL · 1996 to 2008
$1.9M
Intramural NIH HHS Z01 BC005652NCI NIH HHS U01 CA078527
6 · The paper itself

Abstract

Human papillomavirus (HPV) 16 displays substantial sequence variation; four HPV16 lineages (A, B, C, and D) have been described as well as multiple sublineages. To identify molecular events associated with HPV16 carcinogenesis, we evaluated viral variation, the integration of HPV16, and somatic mutation in 96 cervical cancer samples from Guatemala. A total of 65% (62/96) of the samples had integrated HPV16 sequences and integration was associated with an earlier age of diagnosis and premenopausal disease. HPV16 integration sites were broadly distributed in the genome, but in one tumor, HPV16 integrated into the promoter of the IFN regulatory factor 4 (

Indexed as

AdenocarcinomaAdultAgedAged, 80 and overAge FactorsClass I Phosphatidylinositol 3-KinasesDNA, ViralFemaleGenome, ViralGuatemalaHuman papillomavirus 16HumansInterferon Regulatory Factor-4Interferon Regulatory FactorsMiddle AgedMutationClass I Phosphatidylinositol 3-KinasesDNA, ViralInterferon Regulatory Factor-4Interferon Regulatory Factors

Identifiers

PMID32631904
PMCPMC7501218
OpenAlexW3038294347

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.